P.V. Ramprasad Reddy (#1311)
- $ 3 B
- Pharmaceuticals
- India
- M
- 68 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
P.V. Ramprasad Reddy sits on the board of generics maker Aurobindo Pharma, which he cofounded in 1986. Aurobindo Pharma makes drugs to treat a range of diseases such as diabetes and cardiac ailments. The company gets nearly three-fourths of its revenue from the U.S. and Europe. Starting with a single manufacturing plant, Aurobindo expanded into a global company with 35 manufacturing plants and 9 R&D Centers that serve more than 150 countries. In July 2025, Aurobindo struck a $250 million deal to acquire U.S. drugmaker Lannett to expand its American manufacturing footprint.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped P.V. Ramprasad Reddy’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking P.V. Ramprasad Reddy’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $3.3B
(May 4, 2026)
© Iconic Billionaires